文献速递食管与纵隔外科

食管切除术中遵循质量指标与各期食管癌生存改善相关

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer.
PubMed 文献 · Ann Thorac Surg · 2017-01-18

该研究基于美国国家癌症数据库分析食管切除术患者对质量指标(R0切除、淋巴结清扫≥15枚、局部晚期新辅助治疗)的依从性及其与总生存的关系。结果显示高容量中心更易达标,且全部达标与早期和局部晚期患者死亡风险显著降低相关,但当前依从率仍较低。

要点

  • 高容量中心(年食管切除术>20例)更易达到质量指标。
  • 全部质量指标达标与早期和局部晚期食管癌死亡风险显著降低相关。
  • 当前仅少数患者接受了符合推荐质量指标的诊疗。

核心结论

  • 遵循推荐的质量指标与早期和局部晚期食管癌患者总生存改善独立相关。
  • 目前仅少数患者接受的诊疗符合这些推荐。

研究设计与样本

  • 回顾性队列研究,数据来自美国国家癌症数据库。
  • 早期食管癌分析纳入1998至2012年,局部晚期分析因新辅助状态自2006年可用而始于2006年。
  • 早期组16040例中4908例(30.6%)接受食管切除术;局部晚期组20437例中7747例(37.9%)接受食管切除术。

主要发现

  • 早期组中4518/4672例(96.7%)达到R0切除,1395/4686例(29.8%)淋巴结清扫≥15枚。
  • 局部晚期组中5977/6966例(85.8%)接受诱导治疗,6394例(91.8%)达到R0切除,2852例(40.9%)淋巴结清扫≥15枚。
  • 高容量中心与达到早期两项指标独立相关(OR 2.2,95%CI 1.9-2.5),也与达到局部晚期全部质量指标相关(OR 2.17,95%CI 1.92-2.46)。
  • 全部质量指标达标与早期组死亡风险降低相关(HR 0.27,95%CI 0.18-0.39),局部晚期组亦相关(HR 0.54,95%CI 0.40-0.73)。

关键数值与推荐

  • 质量指标包括:R0切除、淋巴结清扫≥15枚、局部晚期肿瘤接受诱导治疗。
  • 早期食管癌定义为临床T1A至T2N0且肿瘤<2cm、高分化。
  • 局部晚期食管癌定义为临床IIB至IIIB期。
  • 高容量中心定义为年食管切除术>20例。

临床怎么用

  • 心胸外科医生应关注食管切除术质量指标,包括R0切除、淋巴结清扫≥15枚及局部晚期患者接受诱导治疗。
  • 高容量中心更易达到质量指标,提示集中化诊疗可能有助于改善依从性。
  • 遵循质量指标与生存改善相关,应作为临床实践和质控的参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Quality measures for patients with early and locally advanced esophageal cancer undergoing esophagectomy have been made by national organizations. The rate of adherence to these measures as well as their association with overall survival are unknown. METHODS: Esophagectomy patients were abstracted from the National Cancer Database. Because neoadjuvant status was available since 2006, the analysis of locally advanced patients began at this time point. Selected measures included: R0 resection, evaluation of 15 or more lymph nodes, and induction therapy for locally advanced tumors. Multivariate models identified variables associated with achieving quality measures. A Cox proportional hazards model evaluated factors associated with mortality. RESULTS: From 1998 to 2012, 4,908 of 16,040 (30.6%) early-stage esophageal cancer patients (clinical T1A to T2N0 <2cm, well-differentiated) underwent esophagectomy. Of 4,672 patients 4,518 (96.7%) achieved R0 resection and 1,395 of 4,686 (29.8%) had 15 or more lymph nodes sampled. High-volume center type (>20 esophagectomies/year) was independently associated with meeting both measures (odds ratio [OR] 2.2, 95% confidence interval [CI]: 1.9 to 2.5). From 2006 to 2012, 7,747 of 20,437 (37.9%) locally advanced patients (clinical Stage IIB to IIIB) received esophagectomy. Of 6,966 patients 5,977 (85.8%) received induction therapy, 6,394 (91.8%) had R0 resection, and 2,852 (40.9%) had 15 or more lymph nodes sampled. High-volume center type was, again, associated with increased likelihood of meeting all quality measures (OR 2.17, 95% CI: 1.92 to 2.46). Meeting all quality measures was associated with the largest decrease in mortality for both early-stage (hazard ratio [HR] 0.27, 95% CI: 0.18 to 0.39) and locally advanced (HR 0.54, 95% CI: 0.40 to 0.73) esophageal cancer patients. CONCLUSIONS: Adherence to recommended quality measures is independently associated with improved overall survival in both early and locally advanced stages of esophageal cancer. Currently, few patients are receiving care in accordance with these recommendations.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Samson P, Puri V, Broderick S, et al. Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer. Ann Thorac Surg. 2017. PMID: 28109569. doi:10.1016/j.athoracsur.2016.09.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。